The Cardiovascular Ultrasound Market is poised for significant growth, with global revenue reaching USD 1.2 billion in 2022. According to the latest analysis report by Future Market Insights, the market is expected to expand at a compound annual growth rate (CAGR) of 7.2% from 2023 to 2033, reaching a projected valuation of USD 2.6 billion by the end of the forecast period.
A key driver of this growth is the Transthoracic Echocardiography segment, which is anticipated to be the highest revenue-generating segment in the market. This segment is expected to achieve a CAGR of 7.3% from 2023 to 2033, reflecting the increasing adoption of this non-invasive imaging technique for assessing cardiovascular health.
The demand for advanced cardiovascular imaging technologies continues to rise due to the growing prevalence of heart diseases and the need for timely and accurate diagnosis. As healthcare providers increasingly prioritize patient-centric approaches, the cardiovascular ultrasound market is well-positioned to meet the evolving needs of clinicians and patients alike.
The three leading causes of death in the country are heart disease, heart attacks, and stroke. The propensity to CVD has increased due to changing lifestyles. The CDC reports that 28.2 million Americans received a heart disease diagnosis in 2017. The function of the heart’s valves, plaque buildup, and cardiac pumping capability are all examined using ultrasound technology.
Ultrasound imaging is a noninvasive medical diagnostic tool that helps doctors diagnose and treat medical issues. The images of the veins and arteries in the body are produced by vascular ultrasonography.
A Doppler ultrasound scan is often part of a vascular ultrasound evaluation. They can also show blood flowing through arteries. The global cardiovascular ultrasound treatment market is being driven by factors such as the rising prevalence of heart diseases and the growing acceptability of cardiovascular ultrasound systems over older invasive cardiac diagnostic procedures.
Echocardiography, also known as echocardiography, is a medical imaging technique that uses high-frequency sound waves to produce images of the heart and surrounding blood vessels. This non-invasive test is used to evaluate the structure and function of the heart, as well as detect abnormalities and diagnose various cardiovascular diseases.
Global Cardiovascular Ultrasound Industry Competitive Landscape
- GE Healthcare
- Koninklijke Philips
- Siemens Healthineers AG
- Hitachi Medical Corp.
- Samsung Medison Co. Ltd.
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Chison Wuxi Xiangsheng Medical Technology Co., Ltd.
- Fujifilm Sonosite, Inc
Some of the recent developments of key Global Cardiovascular Ultrasound Industry providers are as follows:
- In October 2020, GE Healthcare got FDA 510k clearance for their extreme edition package of vivid cardiovascular ultrasound devices, which contains new artificial intelligence (AI)-based features that enable doctors to obtain faster, more consistent assessments.
- In October 2020, Royal Philips introduced the Ultrasound 3300 in India. OB/GYN, cardiovascular imaging, and general imaging are a few of the applications for the device.
- In August 2020, Philips announced the release of its new Affinity CVx and 7.0 for EPIQ CVx cardiovascular ultrasound systems, which include enhancements to boost diagnostic confidence and improve the user experience.
Market Segments Covered in Global Cardiovascular Ultrasound Industry Analysis
By Type:
- Fetal Echocardiography
- Transthoracic Echocardiography
- Transesophageal Echocardiography
- Others
By Technology:
- 2D
- 3D/4D
- Doppler
By Display Type:
- B/W
- Color
By End-use:
- Hospitals
- Diagnostic Centers
- Ambulatory Care Centers
- Other End-uses
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
